This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Flonza Isa: Innovator in SARS-CoV-2 Treatment
Introduction
Flonza Isa is a notable inventor based in Yonkers, NY (US). He has made significant contributions to the field of medical science, particularly in the fight against COVID-19. His innovative work focuses on methods for treating and preventing SARS-CoV-2 infections.
Latest Patents
Flonza Isa holds a patent titled "Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies." This invention provides methods for preventing and treating SARS-CoV-2 infections, COVID-19, or symptoms thereof. The methods feature the administration of one or more antigen-binding molecules, such as antibodies, that bind to a surface protein of SARS-CoV-2, specifically the spike protein. He has 1 patent to his name.
Career Highlights
Flonza Isa is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to work on groundbreaking research and development in the field of therapeutics. His expertise and dedication to innovation have positioned him as a key player in the pharmaceutical industry.
Collaborations
Flonza collaborates with talented professionals, including Samit Ganguly and Sumathi Sivapalasingam, who contribute to the advancement of their shared goals in medical research.
Conclusion
Flonza Isa's work exemplifies the spirit of innovation in addressing global health challenges. His contributions to the treatment of SARS-CoV-2 infections highlight the importance of research and collaboration in the fight against pandemics.